Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma.

Asthma / therapy Australia Biomedical Research Clinical Audit Decision Support Systems, Clinical Disease Management Electronic Health Records Humans Severity of Illness Index Surveys and Questionnaires
Asthma Clinical decision support systems Difficult asthma Electronic platform REDCap Severe asthma Systematic assessment

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
Historique:
received: 16 12 2018
revised: 22 02 2019
accepted: 27 02 2019
pubmed: 8 4 2019
medline: 18 8 2020
entrez: 8 4 2019
Statut: ppublish

Résumé

Severe asthma is complex and heterogeneous; ad hoc outpatient assessment can be suboptimal. Systematic evaluation improves outcomes and is recommended by international guidelines. Electronic templates improve physician performance and clinical processes, and may be useful in severe asthma systematic evaluation. We developed the Severe Asthma Global Evaluation (SAGE) electronic platform to streamline this process, via Research Electronic Data Capture (REDCap). It incorporates: a questionnaire battery for patient completion before clinical consultation; asthma and comorbidity modules; a clinical summary page in an asthma management module; a nurse educator module; a structured panel discussion record; and an automatically generated report incorporating all key data. SAGE incorporates 282 clinician input fields, with a typical consultation requiring completion of 169. To streamline the process SAGE contains 34 autocalculations and 20 decision support tools. It incorporates all 95 core variables of the International Severe Asthma Registry, with which it is directly compatible. SAGE improves symptom control and exacerbations in patients with difficult asthma. In conclusion, we developed and validated an electronic platform that facilitates a comprehensive but streamlined systematic evaluation of severe asthma that is available for free download via REDCap. Its use enhances management of patients with severe asthma and facilitates audit and international research collaboration.

Identifiants

DOI: 10.1016/j.jaip.2019.02.042 PMID: 30954467
pubmed: 30954467
pii: S2213-2198(19)30265-X
doi: 10.1016/j.jaip.2019.02.042
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1440-1449

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Eve Denton (E)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia; Public Health & Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: e.denton@alfred.org.au.

Fiona Hore-Lacy (F)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia.

Naghmeh Radhakrishna (N)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia.

Annie Gilbert (A)

Department of Applications and Knowledge Management, Alfred Health, Melbourne, Australia.

TunnRen Tay (T)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia.

Joy Lee (J)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia.

Eli Dabscheck (E)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia.

Erin S Harvey (ES)

Australasian Severe Asthma Network, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, Australia.

Lakmini Bulathsinhala (L)

Optimum Patient Care, Cambridge, United Kingdom.

James Fingleton (J)

Respiratory Medicine, Capital and Coast District Health Board, Wellington, New Zealand; Asthma Division, Medical Research Institute of New Zealand, Wellington, New Zealand.

David Price (D)

Optimum Patient Care, Cambridge, United Kingdom; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.

Peter G Gibson (PG)

Australasian Severe Asthma Network, Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, Australia; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.

Robyn O'Hehir (R)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia; Respiratory, Allergy and Clinical Immunology, Central Clinical School, Monash University, Melbourne, Australia.

Mark Hew (M)

Allergy, Asthma & Clinical Immunology, The Alfred Hospital, Melbourne, Australia; Public Health & Preventive Medicine, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Audit clinique › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Sciences de l'information › Informatique › Informatique médicale › Applications de l'informatique médicale › Systèmes d'information › Systèmes d'aide à la décision clinique › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Documents › Dossiers médicaux › Systèmes informatisés de dossiers médicaux › Dossiers médicaux électroniques › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Indicateurs d'état de santé › Acuité des besoins du patient › Indice de gravité de la maladie › Severe Asthma Global Evaluation (SAGE): An...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Severe Asthma Global Evaluation (SAGE): An...